200,000+ products from a single source!
sales@angenechem.com
CAS No: 1194961-19-7 Catalog No: AG000IVF MDL No:
Title | Journal |
---|---|
Functional characterization of BTK(C481S) mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors. | Leukemia 20150401 |
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration. | Leukemia 20120701 |
Discovery and development of spleen tyrosine kinase (SYK) inhibitors. | Journal of medicinal chemistry 20120426 |
Critical role for Syk in responses to vascular injury. | Blood 20111103 |
Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor. | Bioorganic & medicinal chemistry letters 20111015 |
© 2019 Angene International Limited. All rights Reserved.